The effect of Covid-19 on the innovation and corporate venturing activities of organizations.
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr ir. Prof VJA van de VrandeResearch Location
N/ALead Research Institution
Erasmus UniversityResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Economic impacts
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Goal As a result of the Covid-19 pandemic, companies' innovation activities, especially those that are more exploratory in nature and where companies collaborate with external startups, have come under pressure. This research attempted to determine the effects of the pandemic on the innovation and corporate venturing activities of organizations. Which factors determine whether innovation and corporate venturing activities can survive a crisis such as Covid-19? Results Based on questionnaire research and interviews with more than 40 companies in the Netherlands, we have provided insight into which factors contribute to the resilience of innovation and corporate venturing activities. Based on these findings, we have developed a 'Pandemic Resilience Scan' with which companies can map their resilience themselves. In addition, we have mapped out the best practices to provide companies with tools for innovation management in times of crisis and to help them better protect their innovation activities in the future. The results can be found at www.corporateventuringentrepreneurship.com .